FierceBiotechOriginal article
{"a":[{"_":"Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill","$":{"href":"/biotech/pfizer-chemistry-whiz-debuts-khartis-therapeutics-sights-set-thyroid-eye-disease","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Robert Hoffman, a veteran Pfizer chemist and former XinThera founder, has launched Khartis Therapeutics with $95M in funding to develop a pill for thyroid eye disease.
Importance:3/10
Sentiment:
0.30
startupfinancingthyroid eye diseasefounderpill formulation
Read the original article
Published by FierceBiotech on August 12, 2026 4:36 PM
